# Macrogenics (MGNX) — News

MGNX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mgnx/news

## Recent headlines

- [MacroGenics 2Q revenue $32.8M, estimate $31.8M](https://www.ainvest.com/news/macrogenics-2q-revenue-32-8m-estimate-31-8m-2608) — AInvest Wire, Aug 13, 2026
  MacroGenics (NASDAQ: MGNX) reported second-quarter 2026 revenue of $32.8 million, exceeding the estimated $31.8 million . This marks a significant improvement compared to the same period in 2025, when the company reported a revenue of $22.2 million, representing a year-over-year increase of…
- [MacroGenics says Gilead exercises option, triggers $10M payment](https://www.ainvest.com/news/macrogenics-gilead-exercises-option-triggers-10m-payment-2608) — AInvest Wire, Aug 11, 2026
- [MacroGenics - remains eligible to receive up to approximately $1.6 bln in additional development](https://www.ainvest.com/news/macrogenics-remains-eligible-receive-approximately-1-6-bln-additional-development-2608) — AInvest Wire, Aug 11, 2026
- [Gilead Sciences exercises option for exclusive license for a preclinical bispecific program, triggers $10 mln payment to Macrogenics](https://www.ainvest.com/news/gilead-sciences-exercises-option-exclusive-license-preclinical-bispecific-program-triggers-10-mln-payment-macrogenics-2608) — AInvest Wire, Aug 11, 2026
- [MacroGenics: achieved pre-specified Stage 1 response threshold](https://www.ainvest.com/news/macrogenics-achieved-pre-stage-1-response-threshold-2607) — AInvest Wire, Jul 23, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).